Please sign in to follow a disease.

B-cell non-Hodgkin lymphoma-refractory

Clinical trials for B-cell non-Hodgkin lymphoma-refractory explained in plain language.

Never miss a new study

Get alerted when new B-cell non-Hodgkin lymphoma-refractory trials appear

Sign up with your email to follow new studies for B-cell non-Hodgkin lymphoma-refractory, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug cocktail aims to boost CAR T-Cell success in lymphoma

Disease control Recruiting now

This early-phase trial is testing whether adding two drugs—CC-99282 and rituximab—can help people with non-Hodgkin lymphoma who didn't get a good result from CAR T-cell therapy. The study will enroll 18 adults with relapsed or refractory B-cell lymphoma. Researchers are looking f…

Matched conditions: B-CELL NON-HODGKIN LYMPHOMA-REFRACTORY

Phase 1 • Sponsor: Nathan Denlinger • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC

B-cell non-Hodgkin lymphoma-refractory

Get alerted when new B-cell non-Hodgkin lymphoma-refractory trials appear

New drug cocktail aims to boost CAR T-Cell success in lymphoma